Financial Gravity Asset Management, Inc. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Financial Gravity Asset Management, Inc. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$31
-96.7%
1
-98.2%
0.00%
-100.0%
Q2 2023$949
+24.9%
57
+103.6%
0.00%
-25.0%
Q4 2022$760
-100.0%
28
-93.8%
0.00%
-94.4%
Q3 2022$2,110,000448
+2033.3%
0.07%
Q3 2019$0
-100.0%
21
-41.7%
0.00%
-100.0%
Q2 2019$1,000
-97.7%
36
-98.2%
0.00%
-97.1%
Q1 2019$43,0002,0480.04%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders